Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP429048.RAeU2DeSrp0-xaVseBK-2Jag-DS1U1nWgwd27Qe6CDPPI130_assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429048.RAeU2DeSrp0-xaVseBK-2Jag-DS1U1nWgwd27Qe6CDPPI130_provenance.
• NP433894.RAXYWs735fOEY4H30caYko0wxvpBh7sL-tIYGhFyhvzRE130_assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433894.RAXYWs735fOEY4H30caYko0wxvpBh7sL-tIYGhFyhvzRE130_provenance.
• assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP856892.RAcl8wsUU9M6l3b5maTLV873wJshnI6GBAxHiFhFkXGtw130_assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856892.RAcl8wsUU9M6l3b5maTLV873wJshnI6GBAxHiFhFkXGtw130_provenance.
• NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_provenance.
• NP433909.RAjj3WeriMYdS6VcKiqsx-qQyprA_qeVVPEHSMkndKMEo130_assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433909.RAjj3WeriMYdS6VcKiqsx-qQyprA_qeVVPEHSMkndKMEo130_provenance.
• NP961569.RAgRd-5O71GU8GkrfzDMwCYp5vK0FHs9PrbMhoo9inql4130_assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961569.RAgRd-5O71GU8GkrfzDMwCYp5vK0FHs9PrbMhoo9inql4130_provenance.
• NP429031.RA2PzyJ9yvgF8_owOX01mq1dEtig_NDLGCSdLYeA__Dfs130_assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429031.RA2PzyJ9yvgF8_owOX01mq1dEtig_NDLGCSdLYeA__Dfs130_provenance.
• NP443227.RA3S6QGHEYyeGmoLmeG-on-wHEdCGWhN6B-E2m5hAin2g130_assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP443227.RA3S6QGHEYyeGmoLmeG-on-wHEdCGWhN6B-E2m5hAin2g130_provenance.
• NP856894.RALaR3hnXgbT-GTobGfH11WcwfaP4HMFkHCrGpbFrLEHI130_assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856894.RALaR3hnXgbT-GTobGfH11WcwfaP4HMFkHCrGpbFrLEHI130_provenance.
• NP856889.RAzQfNG6Hn_wLyN3VXrIM0ktLWE7iFABu3Qi0ttvAFy_8130_assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856889.RAzQfNG6Hn_wLyN3VXrIM0ktLWE7iFABu3Qi0ttvAFy_8130_provenance.
• NP856891.RA8To1g7rLfOI8Qa-e61UMmG7_k43u-1fMUl2P0J5V85g130_assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856891.RA8To1g7rLfOI8Qa-e61UMmG7_k43u-1fMUl2P0J5V85g130_provenance.
• NP856895.RA6E1rZVpW4qrTutKC4CgjMAQK62MtocZjMLhrWp8MUpk130_assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856895.RA6E1rZVpW4qrTutKC4CgjMAQK62MtocZjMLhrWp8MUpk130_provenance.